Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum

Infection and Immunity

Volumn 74, Issue 11, 2006, Pages 6226-6235

  Erwin, Alice L ^a   Allen, Simon ^b   Ho, Derek K ^a,c   Bonthius, Paul J ^a   Jarisch, Justin ^a,f   Nelson, Kevin L ^a   Tsao, David L ^d,g   Unrath, William C T ^a   Watson Jr , Michael E ^d   Gibson, Bradford W ^b   Apicella, Michael A ^e   Smith, Arnold L ^a,c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d University of Missouri   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^g Rinat Neuroscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; GALACTOSE; GLYCOSYLTRANSFERASE; HEPTOSE; HEXOSE; LIPOOLIGOSACCHARIDE; MONOCLONAL ANTIBODY; TETRAMER;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BACTERIUM ISOLATION; CONTROLLED STUDY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; HUMAN; IC 50; LGTC GENE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; SERUM; START CODON;

ANIMALS; ANIMALS, NEWBORN; BACTERIAL PROTEINS; BLOOD BACTERICIDAL ACTIVITY; GALACTOSYLTRANSFERASES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HEXOSYLTRANSFERASES; HUMANS; IMMUNITY, NATURAL; INHIBITORY CONCENTRATION 50; LIPOPOLYSACCHARIDES; RATS;

EID: 33750492960     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00722-06     Document Type: Article

References (56)

1. Abdillahi, H., and J. T. Poolman. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180.
2. Allen, S., A. Zaleski, J. W. Johnston, B. W. Gibson, and M. A. Apicella. 2005. Novel sialic acid transporter of Haemophilus influenzae. Infect. Immun. 73:5291-5300.
3. Apicella, M. A., K. M. Bennett, C. A. Hermerath, and D. E. Roberts. 1981. Monoclonal antibody analysis of lipopolysaccharide from Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 34:751-756.
4. Bayliss, C. D., D. Field, and E. R. Moxon. 2001. The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J. Clin. Investig. 107:657-662.
5. Bouchet, V., D. W. Hood, J. Li, J. R. Brisson, G. A. Randle, A. Martin, Z. Li, R. Goldstein, E. K. Schweda, S. I. Pelton, J. C. Richards, and E. R. Moxon. 2003. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. USA 100:8898-8903.
6. Campagnari, A. A., M. R. Gupta, K. C. Dudas, T. F. Murphy, and M. A. Apicella. 1987. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect. Immun. 55:882-887.
7. Campos, J., M. Hernando, F. Roman, M. Pérez-Vázquez, B. Aracil, J. Oteo, E. Lazaro, F. de Abajo, and Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42:524-529.
8. Cerquetti, M., M. L. Ciofi degli Atti, G. Renna, A. E. Tozzi, M. L. Garlaschi, P. Mastrantonio, and HI Study Group. 2000. Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. J. Clin. Microbiol. 38:4649-4652.
9. Cope, L. D., R. Yogev, J. Mertsola, J. L. Latimer, M. S. Hanson, G. H. McCracken, Jr., and E. J. Hansen. 1991. Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B. Mol. Microbiol. 5:1113-1124.
10. Cutbill, S. L., M. M. Farley, and L. G. Donowitz. 1999. Nontypable Haemophilus influenzae meningitis. Pediatr. Infect. Dis. J. 18:660-662.
11. Erwin, A. L., P. J. Bonthuis, J. L. Geelhood, K. L. Nelson, K. W. McCrea, J. R. Gilsdorf, and A. L. Smith. 2006. Heterogeneity in tandem octanucleotides within Haemophilus influenzae lipopolysaccharide biosynthetic gene losA affects serum resistance. Infect. Immun. 74:3408-3414.
12. Erwin, A. L., K. L. Nelson, T. Mhlanga-Mutangadura, P. J. Bonthuis, J. L. Geelhood, G. Morlin, W. C. Unrath, J. Campos, D. W. Crook, M. M. Farley, F. W. Henderson, R. F. Jacobs, K. Mühlemann, S. W. Satola, L. van Alphen, M. Golomb, and A. L. Smith. 2005. Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect. Immun. 73:5853-5863.
13. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, et al. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
14. Fox, K. L., H. H. Yildirim, M. E. Deadman, E. K. Scbweda, E. R. Moxon, and D. W. Hood. 2005. Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilus influenzae, identification of a gene for adding O-acetyl groups. Mol. Microbiol. 58:207-216.
15. Gibson, B. W., J. J. Engstrom, C. M. Johm, W. Hines, and A. M. Falick. 1997. Characterization of bacterial lipooligosaccharides by delayed extraction, matrix-assisted laser desorption time-of-flight mass spectrometry. J. Am. Soc. Mass Spectrom. 8:645-658.
16. Griffin, R., C. D. Bayliss, M. A. Herbert, A. D. Cox, K. Makepeace, J. C. Richards, D. W. Hood, and E. R. Moxon. 2005. Digalactoside expression in the lipopolysaccharide of Haemophilus influenzae and its role in intravascular survival. Infect. Immun. 73:7022-7026.
17. Griffin, R., A. D. Cox, K. Makepeace, J. C. Richards, E. R. Moxon, and D. W. Hood. 2005. Elucidation of the monoclonal antibody 508-reactive, virulence-associated lipopolysaccharide epitope of Haemophilus influenzae and its role in bacterial resistance to complement-mediated killing. Infect. Immun. 73:2213-2221.
18. Herriott, R. M., E. M. Meyer, and M. Vogt. 1970. Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J. Bacteriol. 101:517-524.
19. High, N. J., M. E. Deadman, D. W. Hood, and E. R. Moxon. 1996. The identification of a novel gene required for lipopolysaccharide biosynthesis by Haemophilus influenzae RM7004, using transposon Tn916 mutagenesis. FEMS Microbiol. Lett. 145:325-331.
20. High, N. J., M. E. Deadman, and E. R. Moxon. 1993. The role of a repetitive DNA motif (5′-CAAT-3′) in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope α Gal(1-4)β Gal. Mol. Microbiol. 9:1275-1282.
21. Hood, D. W., M. E. Deadman, T. Allen, H. Masoud, A. Martin, J. R. Brisson, R. Fleischmann, J. C. Venter, J. C. Richards, and E. R. Moxon. 1996. Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol. Microbiol. 22:951-965.
22. Hood, D. W., M. E. Deadman, A. D. Cox, K. Makepeace, A. Martin, J. C. Richards, and E. R. Moxon. 2004. Three genes, lgtF, lic2C and lpsA, have a primary role in determining the pattern of oligosaccharide extension from the inner core of Haemophilus influenzae LPS. Microbiology 150:2089-2097.
23. Hood, D. W., M. E. Deadman, M. P. Jennings, M. Bisercic, R. D. Fleischmann, J. C. Venter, and E. R. Moxon. 1996. DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc. Natl. Acad. Sci. USA 93:11121-11125.
24. Hood, D. W., K. Makepeace, M. E. Deadman, R. F. Rest, P. Thibault, A. Martin, J. C. Richards, and E. R. Moxon. 1999. Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol. Microbiol. 33:679-692.
25. Inzana, T. J. 1983. Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae. J. Infect. Dis. 148:492-499.
26. Inzana, T. J., and M. A. Apicella. 1999. Use of a bilayer stacking gel to improve resolution of lipopolysaccharides and lipooligosaccharides in polyacrylamide gels. Electrophoresis 20:462-465.
27. John, C. M., J. M. Griffiss, M. A. Apicella, R. E. Mandrell, and B. W. Gibson. 1991. The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. J. Biol. Chem. 266:19303-19311.
28. Jones, P. A., N. M. Samuels, N. J. Phillips, R. S. Munson, Jr., J. A. Bozue, J. A. Arseneau, W. A. Nichols, A. Zaleski, B. W. Gibson, and M. A. Apicella. 2002. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Biol. Chem. 277:14598-14611.
29. Kimura, A., and E. J. Hansen. 1986. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect. Immun. 51:69-79.
30. Mandrell, R. E., J. M. Griffiss, and B. A. Macher. 1988. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
31. Månsson, M., D.W. Hood, E. R. Moxon, and E. K. Schweda. 2003. Structural characterization of a novel branching pattern in the lipopolysaccharide from nontypeable Haemophilus influenzae. Eur. J. Biochem. 270:2979-2991.
32. Månsson, M., D. W. Hood, E. R. Moxon, and E. K. Schweda. 2003. Structural diversity in lipopolysaccharide expression in nontypeable Haemophilus influenzae. Identification of L-glycerol-D-manno-heptose in the outer-core region in three clinical isolates. Eur. J. Biochem. 270:610-624.
33. Meats, E., E. J. Feil, S. Stringer, A. J. Cody, R. Goldstein, J. S. Kroll, T. Popovic, and B. G. Spratt. 2003. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J. Clin. Microbiol. 41:1623-1636.
34. Melaugh, W., A. A. Campagnari, and B. W. Gibson. 1996. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated. J. Bacteriol. 178:564-570.
35. Melaugh, W., N. J. Phillips, A. A. Campagnari, M. V. Tullius, and B. W. Gibson. 1994. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. Biochemistry 33:13070-13078.
36. Nizet, V., K. F. Colina, J. R. Almquist, C. E. Rubens, and A. L. Smith. 1996. A virulent nonencapsulated Haemophilus influenzae. J. Infect. Dis. 173:180-186.
37. Novak, R., and E. Tuomanen. 1999. Pathogenesis of pneumococcal pneumonia. Semin. Respir. Infect. 14:209-217.
38. O'Neill, J. M., J. W. St. Geme III, D. Cutter, E. E. Adderson, J. Anyanwu, R. F. Jacobs, and G. E. Schutze. 2003. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J. Clin. Microbiol. 41:3064-3069.
39. Phillips, N. J., M. A. Apicella, J. M. Griffiss, and B. W. Gibson. 1992. Structural characterization of the cell surface lipooligosaccharides from a nontypable strain of Haemophilus influenzae. Biochemistry 31:4515-4526.
40. Rahman, M. M., X. X. Gu, C. M. Tsai, V. S. Kolli, and R. W. Carlson. 1999. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274. Glycobiology 9:1371-1380.
41. Saladino, R. A., A. M. Stack, G. R. Fleisher, C. M. Thompson, D. E. Briles, L. Kobzik, and G. R. Siber. 1997. Development of a model of low-inoculum Streptococcus pneumonias intrapulmonary infection in infant rats. Infect. Immun. 65:4701-4704.
42. Schweda, E. K. H., J. A. Jonasson, and P.-E. Jansson. 1995. Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147, and a fresh clinical isolate, ACY1: evidence for intrastrain heterogeneity with the production of mutually exclusive sialylated or elongated glycoforms. J. Bacteriol. 177:5316-5321.
43. Severi, E., G. Randle, P. Kivlin, K. Whitfield, R. Young, R. Moxon, D. Kelly, D. Hood, and G. H. Thomas. 2005. Sialic acid transport in Haemophilus influenzae is essential for lipopolysaccharide sialylation and serum resistance and is dependent on a novel tripartite ATP-independent periplasmic transporter. Mol. Microbiol. 58:1173-1185.
44. Sharelzsky, C., T. D. Edlind, J. J. LiPuma, and T. L. Stull. 1991. A novel approach to insertional mutagenesis of Haemophilus influenzae. J. Bacteriol. 173:1561-1564.
45. Smith, A. L., D. H. Smith, D. R. Averill, Jr., J. Marino, and E. R. Moxon. 1973. Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect. Immun. 8:278-290.
46. Spinola, S. M., Y. A. Kwaik, A. J. Lesse, A. A. Campagnari, and M. A. Apicella. 1990. Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope. Infect. Immun. 58:1558-1564.
47. Tullius, M. V., N. J. Phillips, N. K. Scheffler, N. M. Samuels, R. S. Munson, Jr., E. J. Hansen, M. Stevens-Riley, A. A. Campagnari, and B. W. Gibson. 2002. The lbgAB gene cluster of Haemophilus ducreyi encodes a β-1,4-galactosyltransferase and an α-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis. Infect. Immun. 70:2853-2861.
48. van der Woude, M. W., and A. J. Baumler. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581-611.
49. Weiser, J. N. 2000. The generation of diversity by Haemophilus influenzae. Trends Microbiol. 8:433-435.
50. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
51. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640.
52. Weiser, J. N., M. Shchepetov, and S. T. H. Chong. 1997. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943-950.
53. Williams, B. J., G. Morlin, N. Valentine, and A. L. Smith. 2001. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect. Immun. 69:695-705.
54. Yamasaki, R., W. Nasholds, H. Schneider, and M. A. Apicella. 1991. Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components. Mol. Immunol. 28:1233-1242.
55. k (Galα1-4Galβ1-4Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect. Immun. 68:5261-5268.
56. Zhou, D., D. S. Stephens, B. W. Gibson, J. J. Engstrom, C. F. McAllister, F. K. Lee, and M. A. Apicella. 1994. Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene. J. Biol. Chem. 269:11162-11169.